Tumor idiotype protein

The **tumor idiotype protein** refers to the unique immunoglobulin variable (V) region sequence expressed by a malignant B cell clone, particularly in B cell lymphomas and plasma cell tumors[1][2]. This idiotype is a tumor-specific antigen because it arises from gene rearrangements unique to each cancer clone. Therapeutically, the idiotype protein can be directly targeted either by active vaccination (using the idiotype protein as an immunogen to induce anti-tumor immunity) or by passive immunotherapy (using monoclonal antibodies that recognize the tumor idiotype). The immune system's regulation of idiotype and anti-idiotype networks has shaped vaccine strategies for breaking tolerance and inducing potent tumor-specific responses. Because each tumor's idiotype is unique, this approach is highly personalized. This "target" is not a single, universal molecule but a category of antigens defined by tumor-specific immunoglobulin sequences, so it is not a canonical molecular target like a receptor or enzyme. Therefore, as a "target name," "Tumor idiotype protein" is not a singular gene or protein, and its use as a therapeutic target requires customization to each patient's tumor[1][2]. **Note:** - "Tumor idiotype protein" is not a standard, singular protein or receptor; it refers to the clonotypic immunoglobulin variable domain sequence of a tumor, especially in B cell malignancies. Each patient/tumor has its own idiotype[1][2]. - It is a well-recognized therapeutic strategy but does not correspond to a single molecular entity across different patients, so it cannot be mapped to a universal accession number or gene symbol. - Mark "is_incorrect" as true for database ontology use, as this is not a unique molecule or consistent target, but rather a family of unique, patient-specific antigens.

Other names

Idiotype proteinIdiotypic proteinIdiotype antigenTumor-specific idiotypeB cell clonotypic idiotype

Vaccine-induced active immunity (anti-idiotype vaccination), passive immune targeting (monoclonal antibodies against the tumor idiotype protein)